Insights

Unique Cancer Therapies BAKX Therapeutics specializes in developing targeted cancer therapies based on conformationally dynamic protein drivers of the mitochondrial apoptosis pathway. This unique approach offers a competitive edge in the oncology market.

Strategic Funding With a recent funding injection of $25M, BAKX Therapeutics has the financial backing to accelerate research and development efforts, potentially leading to new product launches and market expansion opportunities.

Integrated Tech Platform Utilizing a tech stack that includes Google Analytics, jQuery, and Yoast SEO, BAKX Therapeutics leverages technology to enhance research processes, potentially increasing operational efficiency and attracting collaborations with tech-savvy partners.

Targeted Market Approach By focusing on developing orally active therapeutics that can be used as single agents or in combination with other oncology treatments, BAKX Therapeutics is strategically positioned to target specific segments of the cancer treatment market, potentially leading to increased sales and partnerships.

Competitive Landscape Awareness Understanding the competitive landscape with companies like Bavarian Nordic and Biogen allows BAKX Therapeutics to identify gaps in the market, differentiate its offerings, and tailor sales strategies to capture market share effectively.

Similar companies to BAKX Therapeutics

BAKX Therapeutics Tech Stack

BAKX Therapeutics uses 8 technology products and services including Google Analytics, Google Font API, Font Awesome, and more. Explore BAKX Therapeutics's tech stack below.

  • Google Analytics
    Analytics
  • Google Font API
    Font Scripts
  • Font Awesome
    Font Scripts
  • jQuery
    Javascript Libraries
  • Revslider
    Miscellaneous
  • Yoast SEO
    Search Engines
  • X-XSS-Protection
    Security
  • Twenty Twenty-One
    Web Platform Extensions

Media & News

BAKX Therapeutics's Email Address Formats

BAKX Therapeutics uses at least 1 format(s):
BAKX Therapeutics Email FormatsExamplePercentage
FLast@bakxtx.comJDoe@bakxtx.com
50%
FLast@bakxtx.comJDoe@bakxtx.com
50%

Frequently Asked Questions

Where is BAKX Therapeutics's headquarters located?

Minus sign iconPlus sign icon
BAKX Therapeutics's main headquarters is located at New York | Boston, US. The company has employees across 1 continents, including North America.

What is BAKX Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
BAKX Therapeutics's official website is bakxtx.com and has social profiles on LinkedIn.

What is BAKX Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
BAKX Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BAKX Therapeutics have currently?

Minus sign iconPlus sign icon
As of June 2024, BAKX Therapeutics has approximately 11 employees across 1 continents, including North America. Key team members include Head Of Protein Sciences/Biochemistry/Biophysics: N. G.Founder & Chief Executive Officer: S. K.Director Of Finance And Operations: J. M.. Explore BAKX Therapeutics's employee directory with LeadIQ.

What industry does BAKX Therapeutics belong to?

Minus sign iconPlus sign icon
BAKX Therapeutics operates in the Biotechnology Research industry.

What technology does BAKX Therapeutics use?

Minus sign iconPlus sign icon
BAKX Therapeutics's tech stack includes Google AnalyticsGoogle Font APIFont AwesomejQueryRevsliderYoast SEOX-XSS-ProtectionTwenty Twenty-One.

What is BAKX Therapeutics's email format?

Minus sign iconPlus sign icon
BAKX Therapeutics's email format typically follows the pattern of . Find more BAKX Therapeutics email formats with LeadIQ.

How much funding has BAKX Therapeutics raised to date?

Minus sign iconPlus sign icon
As of June 2024, BAKX Therapeutics has raised $25M in funding. The last funding round occurred on Nov 18, 2021 for $25M.

When was BAKX Therapeutics founded?

Minus sign iconPlus sign icon
BAKX Therapeutics was founded in 2020.
BAKX Therapeutics

BAKX Therapeutics

Biotechnology Research New York | Boston, United States11-50 Employees

We create targeted cancer therapies through unique insights into the conformationally dynamic protein drivers of the mitochondrial apoptosis pathway combined with structure-based drug design and computational simulations  

We have built an integrated & iterative platform based on knowledge, experimentation, and simulation that allows us to better interrogate and harness the power of regulated apoptosis

We are developing a suite of orally active therapeutics which can act as single agents or in combination with other oncology therapies to create better and lasting outcomes for cancer patients

Section iconCompany Overview

Headquarters
New York | Boston, US
Website
bakxtx.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $25M

    BAKX Therapeutics has raised a total of $25M of funding over 1 rounds. Their latest funding round was raised on Nov 18, 2021 in the amount of $25M.

Section iconFunding & Financials

  • $25M

    BAKX Therapeutics has raised a total of $25M of funding over 1 rounds. Their latest funding round was raised on Nov 18, 2021 in the amount of $25M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.